Understanding Inflammatory Bowel Disease in Canadian Children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The CIDsCaNN Network aims to investigate the reasons behind the high prevalence of Inflammatory Bowel Disease (IBD) among children and adolescents in Canada. This observational study will enroll a diverse cohort of young patients diagnosed with IBD, including Crohn's Disease and Ulcerative Colitis, to explore environmental risk factors and their impact on the microbiome and genetic susceptibility. By assessing treatment outcomes such as symptom resolution and intestinal healing, the study seeks to identify best practices for managing IBD in pediatric populations. The findings will contribute to improving care and treatment strategies nationally.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* diagnosed with IBD - Crohn's, ulcerative colitis or inflammatory bowel disease undefined

Exclusion Criteria:

* Refusal to give informed consent

Where it's running

• Alberta Children'S Hospital
  Calgary, Alberta, Canada Recruiting
• Stollery Children'S Hospital
  Edmonton, Alberta, Canada Recruiting
• Children'S Hospital of Bc
  Vancouver, British Columbia, Canada Recruiting
• Winnipeg Children'S Hospital
  Winnipeg, Manitoba, Canada Recruiting
• Janeway Children'S Health & Rehabilitation Centre
  St. John's, Newfoundland and Labrador, Canada Recruiting
• Izaak Walton Killam Hospital (Iwk)
  Halifax, Nova Scotia, Canada Recruiting

Study contacts

• Principal investigator: Anne M Griffiths, MD, FRCPC — The Hospital for Sick Children
• Study coordinator: Anne M Griffiths, MD, FRCPC
• Email: anne.griffiths@sickkids.ca
• Phone: (416) 813-8757

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ath-063: Testing a new treatment for moderately to severely active ulcerative colitis in patients who have tried other biologics

  This study tests ATH-063 to see if it helps people with moderate to severe ulcerative colitis who did not respond to or relapsed after prior biologic therapy.

  Recruiting at 4 sites Phase 2 Athos Therapeutics Inc · Miami, Florida and 3 other locations · NCT07513181

• Self-management program to improve health in inflammatory bowel disease

  A digital self-management program is being tested to see if it helps people with inflammatory bowel disease feel better and manage their symptoms alongside standard care.

  Recruiting University of Michigan · Ann Arbor, Michigan · NCT07456566

• Lyophilized fecal microbiota transplant for adults with active ulcerative colitis

  This trial will test whether a dried (lyophilized) fecal microbiota transplant helps adults with active ulcerative colitis when added to their current treatment or started alongside a new advanced medication.

  Recruiting Phase 1 University of Alberta · Calgary, Alberta and 1 other locations · NCT07401680

• Long-acting antibody treatments alone and in combinations for moderate to severe ulcerative colitis

  This tests long-acting antibody medicines, given after an IV induction and then as under-the-skin maintenance, to see if they help adults with moderate to severe ulcerative colitis.

  Recruiting at 276 sites Phase 2 Spyre Therapeutics, Inc. · Canoga Park, California and 275 other locations · NCT07012395

• Observational study comparing inflammatory markers in IBD and non-IBD participants

  This study is trying to see how inflammation levels in people with Crohn's Disease and Ulcerative Colitis compare to those without these conditions when they start new treatments.

  Recruiting University of Nottingham · Nottingham, Nottinghamshire · NCT06956703

• Evaluating robotic surgery for inflammatory bowel disease

  This study is testing if robotic surgery can be a good option for adults with inflammatory bowel disease, like Crohn's or ulcerative colitis, compared to traditional surgery methods.

  Recruiting at 6 sites University Hospitals Coventry and Warwickshire NHS Trust · Coventry, West Midlands and 5 other locations · NCT06579443

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.